The FDA asked Mayne and Mithra for additional bioequivalence data in comparison to Nuvaring. From what I have read, it looks like the FDA now have 2 months to respond again to Mayne, either with approval, additional questions or rejection. Anything is possible, but my strong assumption is that Mayne will have provided all of the necessary information and the FDA will approve. Time will tell.
- Forums
- ASX - By Stock
- New Product Approvals
The FDA asked Mayne and Mithra for additional bioequivalence...
-
- There are more pages in this discussion • 190 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.17 |
Change
-0.090(2.11%) |
Mkt cap ! $354.7M |
Open | High | Low | Value | Volume |
$4.22 | $4.22 | $4.12 | $753.9K | 181.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9287 | $4.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.19 | 894 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9287 | 4.170 |
2 | 469 | 4.160 |
2 | 409 | 4.150 |
2 | 1063 | 4.140 |
3 | 6063 | 4.130 |
Price($) | Vol. | No. |
---|---|---|
4.190 | 894 | 1 |
4.200 | 1063 | 2 |
4.210 | 1063 | 2 |
4.220 | 169 | 1 |
4.230 | 4947 | 5 |
Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online